MCF Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.9K Hold
70,000
﹤0.01% 515
2025
Q4
$167K Sell
70,000
-5,000
-7% -$13.7K 0.01% 339
2025
Q3
$214K Buy
75,000
+50,000
+200% +$171K 0.01% 239
2025
Q2
$94.3K Hold
25,000
0.01% 318
2025
Q1
$113K Buy
+25,000
New +$132K 0.01% 288

Other funds holding HCAT

MCF Advisors's HCAT Position: Q1 2026 in Review

MCF Advisors held its Health Catalyst (HCAT) position steady in Q1 2026 at 70,000 shares worth $88.9K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

MCF Advisors first reported a position in HCAT in Q1 2025 and has held it in 5 quarters since. The position peaked at $214K in Q3 2025. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • MCF Advisors held 70,000 shares of Health Catalyst worth $88.9K as of Q1 2026.
  • MCF Advisors left its Health Catalyst share count unchanged in Q1 2026.
  • Health Catalyst made up ﹤0.01% of MCF Advisors's portfolio in Q1 2026, its #515 holding.
  • MCF Advisors first reported a position in Health Catalyst in Q1 2025 and has held it in 5 quarters since.
  • MCF Advisors's Health Catalyst position peaked at $214K in Q3 2025.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.